POTASSIUM CITRATE EXTENDED RELEASE is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Strides Pharma Inc.. The primary component is Potassium Citrate.
Product ID | 42543-407_55d8a58f-3e4e-4dd4-9b92-bd747e874f8c |
NDC | 42543-407 |
Product Type | Human Prescription Drug |
Proprietary Name | POTASSIUM CITRATE EXTENDED RELEASE |
Generic Name | Potassium Citrate |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2017-11-01 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA206813 |
Labeler Name | Strides Pharma Inc. |
Substance Name | POTASSIUM CITRATE |
Active Ingredient Strength | 10 meq/1 |
Pharm Classes | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2017-11-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA206813 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2017-11-01 |
Ingredient | Strength |
---|---|
POTASSIUM CITRATE | 10 meq/1 |
SPL SET ID: | 5f38b02c-703c-4fc2-b833-654e41bd617f |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
70518-1221 | POTASSIUM CITRATE EXTENDED RELEASE | POTASSIUM CITRATE EXTENDED RELEASE |
42543-408 | POTASSIUM CITRATE EXTENDED RELEASE | POTASSIUM CITRATE EXTENDED RELEASE |
42543-407 | POTASSIUM CITRATE EXTENDED RELEASE | POTASSIUM CITRATE EXTENDED RELEASE |
42543-406 | POTASSIUM CITRATE EXTENDED RELEASE | POTASSIUM CITRATE EXTENDED RELEASE |
71335-1706 | POTASSIUM CITRATE EXTENDED RELEASE | POTASSIUM CITRATE EXTENDED RELEASE |
0245-0070 | Potassium Citrate | potassium citrate |
0245-0071 | Potassium Citrate | potassium citrate |
0178-0600 | UROCIT-K | potassium citrate |
0178-0610 | UROCIT-K | potassium citrate |
0178-0615 | UROCIT-K | potassium citrate |